Skip to main content

Animations

MJFF Publications

7901 - 7910 of 9030 Results
Title
Year
  • Year
  • 2020
  • 2021
  • 2025
  • 2020
  • 2017
  • 2017
  • 2024
  • 2013
  • 2017
  • 2012
  • Summary Details
    OPEN
    Title: Deep Learning Identifies Digital Biomarkers for Self-Reported Parkinson's Disease
    Journal Name: Patterns
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.patter.2020.100042
    Citation Count: 76
  • Summary Details
    OPEN
    Title: ATG4 family proteins drive phagophore growth independently of the LC3/GABARAP lipidation system
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.molcel.2021.03.001
    Citation Count: 102
  • Summary Details
    OPEN
    Title: Hexokinase 2 interacts with PINK1 to facilitate mitophagy in astrocytes and restrain inflammation-induced neurotoxicity
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.115809
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Prevalence of REM sleep behavior disorder in Sun City, Arizona
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2019.e03140
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: Structural connectome alterations in prodromal and de novo Parkinson's disease patients
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.09.019
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesia
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.14104
    Citation Count: 115
  • Summary Details
    OPEN
    Title: Exploring the Interactions between two Ligands, UCB-J and UCB-F, and Synaptic Vesicle Glycoprotein 2 Isoforms
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.4c00029
    Citation Count: 1
  • Which dyskinesia scale best detects treatment response?
    2013
    Summary Details
    RESTRICTED
    Title: Which dyskinesia scale best detects treatment response?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25321
    Citation Count: 89
  • Changes in neuronal activity of cortico‐basal ganglia–thalamic networks induced by acute dopaminergic manipulations in rats
    2017
    Summary Details
    RESTRICTED
    Title: Changes in neuronal activity of cortico‐basal ganglia–thalamic networks induced by acute dopaminergic manipulations in rats
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.13805
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.03.029
    Citation Count: 31
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.